We recently reported that different purification methods of recombinant adeno-associated virus type 2 (rAAV2) affect the transduction characteristics following subretinal injection. In this study, we examined the roles of contaminant proteins from the HEK-293 cells and helper adenovirus, inactivation of helper adenovirus and cell stress induced by DNA-damaging agents in rAAVmediated retinal transduction. Our results showed that contaminating factors/proteins resulting from the helper E1 deleted adenovirus are possibly responsible for efficient RPE transduction. Future studies of these factors will undoubtedly lead to development of new therapeutic approaches to PR-and RPE-specific retinal diseases.
Introduction
Retinal degeneration (RD) is a family of inherited retinal diseases that lead to vision loss (Rattner, Sun, & Nathans, 1999) . Recent advances in molecular genetics have led to the mapping of more than 130 loci and cloning of more than 70 genes associated with inherited RDs (http://www.sph.uth.tmc.edu/RetNet/). A minority of the inherited RDs are characterized by photoreceptor (PR)-specific gene defects and at least seven genes expressed in retinal pigment epithelium (RPE) are associated with inherited RDs, thus making PR and RPE the principal cell targets for gene therapy in the eye (http:// www.sph.uth.tmc.edu/RetNet/).
Recombinant adeno-associated virus (rAAV) has emerged as a very promising vector for gene therapy because of its ability to transduce dividing and nondividing cells with long-term and stable transgene expression and reduced or lack of immunogenicity (Acland et al., 2001; Ali et al., 2000; LaVail et al., 2000; Liang et al., 2001; McGee Sanftner, Abel, Hauswirth, & Flannery, 2001; Sarra et al., 2001) . Major efforts have been expended in improving the techniques to produce, purify and concentrate rAAV vectors, aiming to efficiently deliver transgenes into target cells. To date, rAAV type 2 (rAAV2) is the serotype that has been the most extensively tested in retinal gene transfer. However, interpretation of previous data on PR and RPE transduction has been complicated by wide variations in terms of purity and concentration of rAAV2 stocks and conflicting results showed varying transduction characteristics after subretinal injection of rAAV2 driven by an ubiquitous CMV promoter (Bennett, Duan, Engelhardt, & Maguire, 1997; Bennett et al., 1999; Grant, Ponnazhagan, Wang, Srivastava, & Li, 1997; Green, Rendahl, Zhou, Ladner, & Coyne, 2001; McGee Sanftner et al., 2001; Rolling et al., 1999; Sarra et al., 2002) .
Factors affecting the transduction characteristics of rAAV are poorly understood. Certain promoters can restrict the activity of transgene expression to certain cell types in the eye. It has been known that rod opsin promoter and interphotoreceptor retinoid binding protein promoter direct transgene expression exclusively in PR, but not in any other retinal cell types (Flannery et al., 1997; Jomary et al., 1999) . In contrast, RPE65 promoter predominantly drives transgene expression in RPE (Boulanger, Liu, Henningsgaard, Yu, & Redmond, 2000; Schwesinger et al., 2001 ). More recently, it has become increasingly evident that different serotypes of rAAV transduce RPE and PR variably and that exchange of surface proteins between different serotypes changes transduction characteristics (Auricchio et al., 2001; Rabinowitz et al., 2002; Yang et al., 2002) .
The transduction characteristics by rAAV2 appear variable among different species of animals in previous studies (Bennett, Anand, Acland, & Maguire, 2000; Bennett et al., 1997 Bennett et al., , 1999 Narfstrom et al., 2003; Sarra et al., 2002; Shen et al., 2003) . Recently we reported that different methods of production and purification of rAAV2 had a dramatic impact on patterns of transgene expression following subretinal injection in rodents (Shen et al., 2003) . In this study, we continued that line to examine several factors that could affect the transduction characteristics of rAAV2. These factors include (i) cellular extract from HEK293 cells, (ii) impurity of rAAV2 from the processes of co-infection of HEK293 cells with E1-defective adenovirus and purification by one-step CsCl 2 density gradient centrifugation (CsCl 2 -rAAV2), (iii) active helper adenovirus particles and (iv) cell genotoxic stress by DNA-damaging agents.
Materials and methods
2.1. Generation and purification of recombinant adenoassociated virus type 2 rAAV used in this study was based on AAV type 2 carrying an enhanced green fluorescent protein (GFP) gene driven by a cytomegalovirus (CMV) promoter (AAV2.CMV.GFP). A total of three batches of AAV2.CMV.GFP were used in this study (Table 1) . Batch A was produced in HEK293 cells with a tripletransfection system in the presence of a helper adenoviral plasmid to provide the essential helper virus genes. Batch A was purified by iodixanol (Optiprep, Nycomed, Oslo, Norway) density step gradient centrifugation followed by heparin column chromatography (HiTrap heparin, Amersham Pharmacia, Uppsala, Sweden) (heparin-rAAV2) and thus the chance of adenovirus contamination is rare or can be considered as free of adenovirus contamination. Batch B was produced in HEK293 cells using an E1-deleted helper adenovirus to generate the rAAV2 particles as reported previously (Lai, Rolling, Baker, & Rakoczy, 2001; Lai et al., 2002) . Batch B was purified in the same way as batch A. Batch C was produced in the same way as batch B but was purified by one-step cesium chloride density gradient centrifugation (CsCl 2 -rAAV2). All the three batches of rAAV2 stocks were dialyzed against PBS and heattreated at 56°C for 30 min to inactivate contaminating adenovirus. The titers of rAAV2 were determined in triplicate by infecting HEK293 cells with different dilutions of vector stocks. The number of cells showing GFP fluorescence was counted and virus titers were reported in transduction units/ml (tu/ml). The levels of wild-type AAV2 contamination were determined by Southern analysis and they were between 0.01% and 0.1% in all batches of rAAV2. Titers of viruses used in this study ranged from 5.0 · 10 7 to 2.0 · 10 10 tu/ml (Table 2) .
2.2. SDS-PAGE assessment of CsCl 2 -rAAV2 and heparin-rAAV2
Ten microliters of heparin-rAAV2 (batch B, Table 1 ) and CsCl 2 -rAAV2 (batch C, Table 1 ) were boiled in SDS-PAGE reducing buffer for 5 min and then electrophoresed on an 8.5% polyacrylamide gel. The gel was then silver-stained according to the protocol by Scopes and Smith (1998) . Briefly, the gel was fixed (50% methanol, 10% acetic acid), destained (5% methanol, 7% acetic acid) and covered in 10% glutaraldehyde before washing thoroughly with water. The gel was soaked in 5 lg/ml dithiothreitol before incubating in 0.1% silver nitrate solution, washed and then agitated in carbonate developing solution (0.0185% formaldehyde solution, 3% sodium carbonate) until the desired level of staining was achieved. Staining was stopped by adding 2.3 M citric acid.
Preparation of crude lysate from HEK293 cells
HEK293 cells (5.0 · 10 6 cells) were washed with PBS and harvested by trypsinization. The harvested cells were further washed twice and centrifuged. The resulting cell pellet was re-suspended in 1.0 ml PBS and disrupted by sonication according to the literature (Rolling & Samulski, 1995) . Cellular debris was eliminated by centrifugation at 1500g for 5 min and the crude lysate from HEK293 cells (CL 293 ) was stored at )80°C for further use.
Subretinal administration of rAAV2
Normal congenic non-pigmented RCS-rdy þ rats of 8-10 weeks age were used in this study. rAAV2 was delivered into the subretinal space in 2.0 ll solution as described previously (Shen et al., 2003) . The following strategies were used to evaluate the effects of possible contaminants in rAAV preparations on the transduction characteristics (Table 2 )--(1) supplement of the crude lysate from HEK293 cells (CL 293 ) into heparin-rAAV2 at a rate of 1:4; (2) co-infection of the retina with heparinrAAV2 mixed with CsCl 2 -rAAV2 in various proportions: (i) 100% heparin-rAAV2, (ii) 3/4 volume of heparinrAAV2, (iii) 3/4 volume of heparin-rAAV2 plus 1/4 volume of CsCl 2 -rAAV2, (iv) 1/4 volume of CsCl 2 -rAAV2 and (v) 100% CsCl 2 -rAAV2; (3) twice heat inactivation (56°C, 30 min) of the possible contamination of helper adenovirus in CsCl 2 -rAAV2 stocks prior to subretinal injection; (4) subretinal injection of heparin-rAAV2 in the presence of DNA-damaging agents: (i) heparin-rAAV2 with 4 mM hydroxyurea (HU), (ii) heparin-rAAV2 with 3 lM trichostatin A (ISA) and (iii) heparin-rAAV2 with 4 mM HU and 3 lM TSA and (iv) intravitreal delivery of 40 mM HU and 30 lM TSA at 12 weeks after subretinal injection of heparin-rAAV2 (Table 2) .
2.5. Detection of GFP fluorescence by fundus fluorescence photography and determination of transduced cell types by fluorescence microscopy GFP expression was monitored by fundus fluorescence photography as early as 2 weeks post-injection and was periodically repeated for 10-14 months post-injection as described previously (Rolling et al., 1999) . Results were assessed by calculating the percentage of GFP positive eyes detected by fluorescence fundus photography and grading transduced area and fluorescence intensity on a scale of 0-4 as follows: score 0 ¼ negative, 1 ¼ isolated patches with weak GFP fluorescence, 2 ¼ isolated patches with moderate GFP fluorescence, 3 ¼ isolated patches of strong GFP fluorescence and 4 ¼ evenly distributed strong GFP fluorescence. To determine the predominant cell types transduced by rAAV2 following subretinal injection, eyes were enucleated and examined by fluorescence microscopy at termination using flat-mounted neuroretinas and RPE-choroid-sclera complexes as well as cryosections as described previously (Lai, Shen, Constable, & Rakoczy, 1999; Shen et al., 2003) .
Results

Protein contaminants in CsCl 2 -rAAV2
The purities of heparin-rAAV and CsCl 2 -rAAV2 viral stocks were compared using SDS-PAGE electrophoresis. Fig. 1 shows that the viral stock of heparin-rAAV (batch B) contained three proteins with sizes corresponding To investigate whether the predominant RPE transduction by CsCl 2 -rAAV2 is related to protein contaminants from HEK293 cells, heparin-rAAV2 free of adenovirus contamination (batch A, Table 1 ) was mixed with HEK293 cellular crude lysate (CL 293 ) at a ratio of 4:1 (volume) for subretinal injection. In general, the onset and transduction intensity by heparin-rAAV2 with or without the presence of CL 293 were not dramatically changed when observed by fundus fluorescence photography from 2 to 12 weeks post-injection (Fig. 2) . Although GFP fluorescence with the addition of CL 293 seemed to be slightly stronger compared with that without CL 293 (Fig. 3A and B) , results of semiquantification did not show statistical significance be- tween these two groups (P > 0:05, Fig. 2B ). With the addition of CL 293 , the transduction characteristics in RPE and PR by heparin-rAAV (batch A) have not been changed when determined by fluorescence microscopy. The GFP fluorescence almost exclusively localized to PR in the neural retina ( Fig. 3C and D) , although a few RPE cells were occasionally transduced (Table 2) .
Twice inactivation of helper adenovirus does not change the transduction characteristics of CsCl 2 -rAAV2
In consideration of a possibility that contamination of active helper adenovirus might contribute to the efficient RPE transduction by CsCl 2 -rAAV2, two CsCl 2 -rAAV2 stocks were twice heated at 56°C for 30 min prior to subretinal injection (Table 2) . Results showed that twice inactivation of active helper adenovirus did not change the transduction characteristics of CsCl 2 -rAAV2 (Table 2) .
Introduction of cell stress by DNA-damaging agents does not change the transduction characteristics of heparin-rAAV2
It has been shown that rAAV2 vectors preferentially transduce cells in the S phase and that DNA-damaging agents HU and TSA increased the transduction efficiency in non-dividing cells (Chen & Townes, 2000; Russell, Alexander, & Miller, 1995; Russell, Miller, & Alexander, 1994) . In this study, PR and RPE were also exposed to heparin-rAAV2 at the presence of HU and TSA, either alone or in combination ( Table 2 ). The used concentrations have been shown to enhance transduction efficiency but without affecting cell viability or proliferative potential in vitro (Chen & Townes, 2000; Russell et al., 1995) . From 2 to 8 weeks post-injection in the present study, GFP fluorescence was not detectable by fundus fluorescence photography in any groups of animals due to the significant decrease in the titer of heparin-rAAV2 (1.6 · 10 7 tu/ml, Table 2 ). Fluorescence microscopy revealed that treatment with HU and TSA slightly increased the transduction efficiency in PR but did not change the transduction characteristics of heparin-rAAV2. In all groups, GFP fluorescence was mainly localized to PR although scattered and weak RPE transduction was visible (Table 2 ). In addition, intravitreal injection of 40 mM HU with 30 lM TSA at 12 weeks post-subretinal injection did not change the cell target specificity of heparin-rAAV2 (Table 2) .
Supplement of a small amount of CsCl 2 -rAAV2 into heparin-rAAV2 dramatically increases the transduction efficiency in RPE
To investigate whether adenoviral contaminants in CsCl 2 -rAAV2 contribute to the predominant RPE transduction, a small amount of CsCl 2 -rAAV 2 was supplemented into heparin-rAAV2 at a ratio of 1:3 (volume) for subretinal injection (Table 2) . In all groups, GFP fluorescence was detectable from 2 weeks postinjection by fundus fluorescence photography. At 2 weeks post-injection, however, more eyes showed GFP fluorescence in the groups infected with CsCl 2 -rAAV2 when compared with those receiving heparin-rAAV2 only (Fig. 4) . The percentages of GFP positive eyes in the groups receiving 100% heparin-rAAV2 (5.0 · 10 8 tu/ml), Fig. 4 . The impact of supplement of rAAV-CsCl 2 on the onset of transgene expression mediated by heparin-rAAV (batch B, see Table 2 ). Positive eyes include anyone expressing GFP signal as detected by fluorescence fundus photography from 2 to 12 weeks post-injection. The titers of rAAV are listed in Table 2 . The data represent 6-12 eyes/group at each time point. h-rAAV ¼ heparin-rAAV.
3/4 heparin-rAAV2 (3.75 · 10 8 tu/ml), 1/4 CsCl 2 -rAAV2 (5.0 · 10 7 tu/ml) and 100% CsCl 2 -rAAV2 (2.0 · 10 8 tu/ ml), were 25%, 25%, 37.5% and 100%, respectively (Fig.  4) . In general, the onset and intensity of transgene expression in CsCl 2 -rAAV2 injected eyes were faster and stronger compared with those receiving heparin-rAAV2, even when a lower titer was used (Figs. 4-6 ). With the same purification method, rAAV2-mediated transgene expression was both time-and titer-dependent and relatively stable transgene expression was observed from 4 to 8 weeks post-injection (Figs. 4-6) . Surprisingly, with the supplement of 1/4 volume of CsCl 2 -rAAV2 into 3/4 volume of heparin-rAAV2 (final titer: 4.25 · 10 8 tu/ml), more eyes (58%) showed GFP fluorescence at 2 weeks post-injection compared to only 25% in the group receiving 100% heparin-rAAV2 (5.0 · 10 8 tu/ml) (Fig. 4) . The intensity of transgene expression at 2 and 4 weeks post-injection was also significantly increased by the supplement of small amount of CsCl 2 -rAAV2 (Figs. 5 and 6, P < 0:05).
Using flat-mounted neural retinas, RPE-choroidscleral complexes and cryosections obtained from whole eyeballs, the transduced cell types by different rAAV2 stocks were determined by fluorescence microscopy. Consistent with previous data (Shen et al., 2003) , subretinal injection of CsCl 2 -rAAV2 predominantly transduced RPE and heparin rAAV2 mainly transduced PR (Table 2) . However, supplement of 1/4 volume of CsCl 2 -rAAV2 into 3/4 volume of heparin-rAAV2 (final titer: 4.25 · 10 8 tu/ml) dramatically increased RPE transduction, showing strong and evenly distributed GFP fluorescence in the RPE cells (Table 2 ). This was very much different from the transduction characteristics of 100% heparin-rAAV2 (5.0 · 10 8 tu/ml) or 3/4 heparin-rAAV2 (3.75 · 10 8 tu/ml), but much more similar to the patterns of transgene expression mediated by 100% CsCl 2 -rAAV2 (2.0 · 10 8 tu/ml) ( Table 2 ).
Discussion
Traditional production of rAAV requires both host cell factors and co-infection with helper adenovirus or herpes virus for the infection cycle. This study examined three batches of rAAV2 viral stocks that were produced and purified by different methods. Batch A was produced with a triple-transfection system in the presence of a helper adenoviral plasmid to provide the essential helper virus genes (Xiao, Li, & Samulski, 1998) . This batch of rAAV was purified by iodixanol density step gradient centrifugation followed by heparin column chromatography. The purification method by heparin column chromatography takes advantage of the binding property of rAAV2 to heparan sulfate proteoglycans (Summerford & Samulski, 1998) . With this method of production and purification, the possibility of contamination by adenovirus factors/proteins is rare. Batch B was produced using an E1-deleted helper adenovirus Fig. 5 . The impact of supplement of rAAV-CsCl 2 on the intensity of transgene expression mediated by heparin-rAAV (batch B, see Table 2 ). GFP fluorescence was graded by analyzing the images obtained from fundus fluorescence photography from 2 to 12 weeks post-injection (see Section 2 for grading scales). The data represent 6-12 eyes/group at each time point. The titers of rAAV are listed in Table 2 . ( Ã ) P < 0:05, 3/4 h-rAAV + 1/4 rAAV-CsCl 2 vs 100% h-rAAV; (y) P < 0:05, 100% rAAV-CsCl 2 vs 100% h-rAAV; and (z) P < 0:05, 3/4 h-rAAV + 1/4 rAAV-CsCl 2 vs 100% h-rAAV; all by unpaired t test. h-rAAV ¼ heparin-rAAV. that involves much more complex elements compared with a helper adenovirus plasmid. Although batch B was purified in the same way as batch A, it is still possible that low levels of heparin-binding proteins resulting from contaminating helper E1 deleted adenovirus were co-purified with rAAV2 particles. Batch C was produced in the same way as batch B but purified by one-step cesium chloride (CsCl 2 ) density gradient centrifugation only. The conventional purification protocol by CsCl 2 density gradient centrifugation inevitably resulted in impure quality of rAAV compared with batch B of rAAV2.
A previous study reported that cellular factors from sonicated extract of HEK293 cells increased rAAV2-mediated transduction efficiency in cells that were normally poorly transduced (Tenenbaum et al., 1999) . One of the important characterizations of HEK293 cells is the presence of adenovirus E1 gene product in this transformed cell line. Therefore, contaminating factors resulting from HEK293 cells could involve adenovirus E1 gene product and other HEK293 cellular proteins. In the present study, we have tested whether cellular proteins extracted from HEK293 cells could change the transduction characteristics of heparin-rAAV2 (batch A). Our results demonstrated that supplementing HEK293 cellular extracts into heparin-rAAV2 did not change the transduction characteristics although the intensity of GFP fluorescence in the neural retina was slightly increased at 2 weeks post-injection. Thus, the sole protein contaminants from HEK293 cells are not responsible for efficient RPE transduction by CsCl 2 -rAAV2. However, a possibility still exists that HEK293 cellular proteins could act cooperatively with the products from helper adenoviral genes, such the adenovirus E1 region (that also exists in HEK293 cells) acts cooperatively with the adenovirus E4 ORF6 region thus enhancing rAAV2-mediated gene transduction in RPE (Trahair, Alexander, Rowe, & Smythe, 2000). As batches A and B were produced by different systems but purified in the same way, analysis of the transduction efficiency of batches A and B allows direct comparison of contaminating proteins resulting from helper adenovirus plasmid and helper E1 deleted adenovirus (batch A vs batch B). Results in Table 2 show that a much higher titer of batch A (2.0 · 10 10 tu/ml) did not efficiently transduce RPE but a much lower titer of batch B (5.0 · 10 8 tu/ml) increased the transduction efficiency in RPE, suggesting that the use of helper E1 deleted adenovirus during rAAV2 production contributed to certain levels of RPE transduction. Batches B and C of rAAV2 were produced exactly in the same way but purified by different methods. As batch B of heparin-AAV2 was supposed to be much purer than batch C of CsCl 2 -AAV2, direct comparison of the transduction characteristics between batches B and C could reveal the effect of different levels of contaminating adenoviral proteins. The results showed less efficient transduction in RPE and stronger transduction in PR with higher titers of heparin-AAV2 (5.0 · 10 8 , 3.75 · 10 8 tu/ml) compared to CsCl 2 -AAV2 (2.0 · 10 8 tu/ml). A previous study has shown that a 110-KDa protein, which has been confirmed to be the human nucleolin, was copurified with AAV2 after CsCl 2 density gradient centrifugation and nucleolin specifically binds to AAV2 (Qiu & Brown, 1999) . In the present study, CsCl 2 -AAV2 preparation probably resulted in the co-purification of factor(s) that are possibly in favor of RPE transduction, or inhibitors of PR transduction, therefore allowing CsCl 2 -AAV2 particles to transduce RPE more efficiently. Purer heparin-AAV2 may have a stronger tropism for PR and it is also possible that further purification of CsCl 2 -AAV2 removed the factors in favor of RPE tropism or the inhibitors of PR transduction, thus allowing heparin-AAV2 to transduce PR more efficiently and with less efficiency in RPE.
The precise identification of contaminating factors/ proteins in CsCl 2 -rAAV2 is time-consuming because of the complexity of contaminating proteins from helper E1 deleted adenovirus. Therefore, direct investigation of the roles of purified factors/proteins from helper E1 deleted adenovirus is currently difficult in the present study. Our further studies showed that the addition of 5.0 · 10 7 tu/ml of CsCl 2 -rAAV2 (batch C) into 3.75 · 10 8 tu/ml of haparin-rAAV2 (batch B) resulting in a final titer of 4.25 · 10 8 tu/ml rAAV2, dramatically increased the transduction efficiency in RPE when compared with Table 2 Transduction characteristics determined by fluorescence microscopy following subretinal injection of rAAV2 various preparations in the rat Table 1 ). b GFP fluorescence was not detectable by fundus fluorescence photography but was observed by fluorescence microscopy using flat-mounted samples and cryosections.
c Four eyes further received intravitreal injection of HU (40 mM) plus TSA (30 lM) in 2.0 ll solution at 12 weeks post-subretinal injection and were followed up for another 8 weeks. Graded GFP fluorescence: score 0 ¼ negative, 1 ¼ isolated patches with weak GFP fluorescence, 2 ¼ isolated patches with moderate GFP fluorescence, 3 ¼ isolated patches of strong GFP fluorescence and 4 ¼ evenly distributed strong GFP fluorescence. that using sole haparin-rAAV2 (5.0 · 10 8 tu/ml of batch B). This further confirmed our hypothesis that contaminating adenoviral proteins in CsCl 2 -rAAV2 are responsible for efficient RPE transduction. Efficient gene transfer requires virus attachment and binding, internalization, migration to the nucleus, decapsidation, conversion to double-stranded DNA and gene expression. It is unclear how supplement of small amounts of CsCl 2 -rAAV2 improved the transduction efficiency in RPE. The present experiment does not permit the determination on which cellular processing the CsCl 2 -rAAV2 acted. Recent data have shown that the adenovirus E4 ORF6 gene product and treatment of target cells with genotoxic stress can dramatically enhance the transduction efficiency by rAAV2 in normally poorly transduced cell lines (Chen & Townes, 2000; Russell et al., 1994 Russell et al., , 1995 . These effects have been correlated with an increased proportion of single-stranded DNA genomes undergoing second-strand synthesis (Ferrari, Samulski, Shenk, & Samulski, 1996; Trahair et al., 2000) . To clarify whether the efficient RPE transduction by CsCl 2 -rAAV2 is related to cell genotoxic stress induced by the impurity of virus preparations, heparin-rAAV2 was also delivered into the subretinal space in the presence of DNA-damaging agents HU and TSA. HU and TSA have been shown to stimulate the conversion of viral single strand DNA to transcriptionally active doublestranded DNA, thus enhancing the transduction efficiency of rAAV2 in vitro (Chen & Townes, 2000; Russell et al., 1994) . In the present study, treatment with HU and TSA increased the intensity of GFP expression in PR but did not enhance the transduction efficiency in RPE. Similarly, the transduction efficiency in RPE by heparin-rAAV2 could not be enhanced by later intravitreal injection of HU and TSA. Our results also showed that twice heat-treatment to inactivate helper adenovirus did not affect the pattern of transgene expression by CsCl 2 -rAAV2. This rules out the possibility that active helper adenovirus particles contribute to efficient RPE transduction but it does not exclude the roles of contaminated adenoviral proteins because adenoviral proteins were still present and may be responsible for RPE tropism of CsCl 2 -rAAV2. In general, our results suggest that the poor transduction of RPE by heparin-rAAV2 is not due to the rate-limiting synthesis of double-strand DNA, but most possibly, could be associated with the poor binding and/or internalization of heparin-rAAV2 onto RPE during the cellular steps of transduction.
